Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Epilepsy Res. 2012 Jul 24;103(2-3):245–253. doi: 10.1016/j.eplepsyres.2012.07.009

Figure 1.

Figure 1

Figure 1

Figure 1

ARV drug levels for (A) efavirenz, (B) nevirapine, and (C) lopinavir for EI-AED and NEI-AED participants based on co-administered EI-AED (carbamazepine or phenytoin) or NEI-AED (gabapentin). For the cases where EI-AED levels were below the reference range (n=6), ARV levels are notated with (x).